Home>
US Stocks>
Cellectar Biosciences

Cellectar Biosciences share price today

(CLRB)

Cellectar Biosciences share price is $0.25 & ₹21.30 as on 25 Dec 2024, 2.30 'hrs' IST

$0.25

▲

-0.02

(-8.05%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Cellectar Biosciences share price in Dollar and Rupees. Guide to invest in Cellectar Biosciences from India. Also see the sentimental analysis on Indian investors investing in Cellectar Biosciences. Get details on the Indian mutual funds that are investing in Cellectar Biosciences. Get Analyst recommendations and forecasts along with all the Cellectar Biosciences's financials.

Cellectar Biosciences share price movements

Today's Low: $0.25
Today's High: $0.28
$0.25
0.0%
Downside
Day's Volatility :9.12%
Upside
9.12%
52 Weeks Low: $0.22
52 Weeks High: $4.45
$0.25
10.4%
Downside
52 Weeks Volatility :94.97%
Upside
94.38%

Cellectar Biosciences Returns

Period	Cellectar Biosciences Inc	Index (Russel 2000)
3 Months	-86.73%	0.0%
6 Months	-89.12%	0.0%
1 Year	-90.25%	0.0%
3 Years	-96.48%	-21.1%

Cellectar Biosciences Key Statistics

in dollars & INR

Previous Close	$0.2757
Open	$0.27
Today's High	$0.2751
Today's Low	$0.25
Market Capitalization	$10.5M
Today's Volume	$792.8K
52 Week High	$4.45
52 Week Low	$0.224
Revenue TTM	$0.0
EBITDA	$-47.4M
Earnings Per Share (EPS)	$-1.41
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-796.67%

How to invest in Cellectar Biosciences from India?

It is very easy for Indian residents to invest directly in Cellectar Biosciences from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Cellectar Biosciences stock in both Indian Rupees (INR) and US Dollars (USD). Search for Cellectar Biosciences or CLRB on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Cellectar Biosciences or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Cellectar Biosciences shares which would translate to 3.408 fractional shares of Cellectar Biosciences as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Cellectar Biosciences, in just a few clicks!

Returns in Cellectar Biosciences for Indian investors in Rupees

Investment Value

₹1,00,000

Cellectar Biosciences investment value today

Current value as on today

₹11,854

Returns

₹88,146

(-88.15%)

Returns from Cellectar Biosciences Stock

₹90,385 (-90.38%)

Dollar Returns

₹2,239 (+2.24%)

Indian investors sentiment towards Cellectar Biosciences

8050.0%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Investment in Cellectar Biosciences from India has grown in the last 30 days as on Dec 26, 2024. 8050.0% more purchase transactions for Cellectar Biosciences in the last 30 days versus the previous period.

900%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Cellectar Biosciences on INDmoney from India has grown in the last 30 days as on Dec 26, 2024. 900% more investors are searching Cellectar Biosciences in the last 30 days versus the previous period.

Global Institutional Holdings in Cellectar Biosciences

Rosalind Advisors, Inc.
8.90%
AIGH Capital Management, LLC
7.75%
Nantahala Capital Management, LLC
6.57%
Vanguard Group Inc
4.18%
ADAR1 Capital Management LLC
2.48%
Geode Capital Management, LLC
0.85%

Analyst Recommendation on Cellectar Biosciences

Buy

90%Buy

10%Hold

0%Sell

Based on 10 Wall street analysts offering stock ratings for Cellectar Biosciences(by analysts ranked 0 to 5 stars)

Based on 10 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Cellectar Biosciences

What analysts predicted

Upside of 2166.68%

Current:

$0.25

Target:

$5.67

Insights on Cellectar Biosciences

Price Movement
In the last 1 month, CLRB stock has moved down by -83.8%
CLRB vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 27.2% return, outperforming this stock by 117.5%
CLRB vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 25.2% return, outperforming this stock by 121.6%

Cellectar Biosciences Technicals Summary

Sell

Neutral

Buy

Cellectar Biosciences is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Cellectar Biosciences Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Cellectar Biosciences Inc	-83.75%	-89.12%	-90.25%	-96.48%	-98.88%
Regeneron Pharmaceuticals, Inc.	-5.12%	-32.01%	-18.29%	12.56%	91.19%
Biontech Se	-3.72%	41.99%	6.11%	-55.22%	226.93%
Alnylam Pharmaceuticals, Inc.	-3.99%	-1.52%	23.75%	50.98%	112.09%
Vertex Pharmaceuticals Incorporated	-12.61%	-13.61%	0.03%	83.58%	86.41%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Cellectar Biosciences Inc	NA	NA	0.0	-1.57	-7.97	-1.66	NA	-0.96
Regeneron Pharmaceuticals, Inc.	17.67	17.67	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.06	0.51	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Cellectar Biosciences Inc	Buy	$10.5M	-98.88%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$78.5B	91.19%	17.67	33.61%
Biontech Se	Buy	$27.4B	226.93%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$31.4B	112.09%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$105.1B	86.41%	32.84	-4.51%

About Cellectar Biosciences

cellectar biosciences is developing phospholipid drug conjugates (pdcs) designed to provide cancer targeted delivery of diverse oncologic payloads to a broad range of cancers and cancer stem cells. cellectar's pdc platform is based on the company's proprietary phospholipid ether analogs. these novel small-molecules have demonstrated highly selective uptake and retention in a broad range of cancers. cellectar's pdc pipeline includes product candidates for cancer therapy and cancer diagnostic imaging. the company's lead therapeutic pdc, clr 131, utilizes iodine-131, a cytotoxic radioisotope, as its payload. clr 131 has been designated as an orphan drug by the us fda and is currently being evaluated in a phase 1 clinical study in patients with relapsed or refractory multiple myeloma and a phase 2 clinical study to assess efficacy in a range of b-cell malignancies. the company is also developing proprietary pdcs for targeted delivery of chemotherapeutics and has several preclinical stage p

Organization	Cellectar Biosciences
Employees	20
CEO	Mr. James V. Caruso
Industry	Health Technology

Management People of Cellectar Biosciences

Name	Title
Mr. James V. Caruso	President, CEO & Director
Mr. Chad J. Kolean CPA	VP, CFO & Secretary
Mr. Jarrod Longcor	Chief Operating Officer
Mr. Darrell Shane Lea	Chief Commercial Officer
Dr. Andrei Shustov M.D.	Senior Vice President of Medical

Important FAQs about investing in Cellectar Biosciences from India :

What is Cellectar Biosciences share price today?

Cellectar Biosciences share price today stands at $0.25, Open: $0.27 ; Previous Close: $0.28 ; High: $0.28 ; Low: $0.25 ; 52 Week High: $4.45 ; 52 Week Low: $0.22. The stock opens at $0.27, after a previous close of $0.28. The stock reached a daily high of $0.28 and a low of $0.25, with a 52-week high of $4.45 and a 52-week low of $0.22.

Can Indians buy Cellectar Biosciences shares?

Yes, Indians can invest in the Cellectar Biosciences (CLRB) from India.

With INDmoney, you can buy Cellectar Biosciences at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Cellectar Biosciences at zero transaction cost.

How can I buy Cellectar Biosciences shares from India?

It is very easy to buy Cellectar Biosciences from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Cellectar Biosciences be purchased?

Yes, you can buy fractional shares of Cellectar Biosciences with INDmoney app.

What are the documents required to start investing in Cellectar Biosciences stocks?

To start investing in Cellectar Biosciences, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.